Announcements Trials
Browse Landscape

Phase

Phase 2 13Phase 2/3 4Phase 1/2 3Phase NA 1Phase 3 1

Status

Withdrawn 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 92Polycystic Ovary Syndrome 11Neoplasm Metastasis 7Infertility 5Carcinoma, Ductal, Breast 5Carcinoma, Lobular 4Osteoporosis 3Neoplasms, Hormone-Dependent 3Neoplasms 3Breast Neoplasms, Male 3Advanced Breast Cancer 3Fallopian Tube Neoplasms 2Carcinoma, Ovarian Epithelial 2Breast Carcinoma In Situ 2Bone Diseases, Metabolic 2Unilateral Breast Neoplasms 1Recurrence 1Peritoneal Neoplasms 1Ovarian Neoplasms 1Osteitis Deformans 1Obesity 1Neoplasms by Site 1Multiple Endocrine Neoplasia Type 1 1Low Grade Serous Ovarian Cancer 1Infertility, Female 1Hormone Receptor-Positive and HER2-Negative Advanced Breast Cancer 1Hereditary Sensory and Autonomic Neuropathies 1Hereditary Breast and Ovarian Cancer Syndrome 1HR+/HER2- Breast Cancer 1HER2+ Breast Cancer 1

Interventions

Paclitaxel 25Doxorubicin 15Carboplatin 14pembrolizumab 10Cisplatin 8Radiotherapy 6Docetaxel 5Chemotherapy, Adjuvant 5Taxes 4Filgrastim 4Brachytherapy 4lenvatinib 3Observation 3trastuzumab deruxtecan 2selinexor 2olaparib 2durvalumab 2Tamoxifen 2Specimen Handling 2Ifosfamide 2Drug Therapy 2sintilimab 1sacituzumab govitecan 1pertuzumab 1nanocis 1liposomal doxorubicin 1ixabepilone 1gallium-diethylenetriaminepentaacetic acid-mannosyl-dextran 1dostarlimab 1atezolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Endometrial Neoplasms × Letrozole × Clear all
NCT05712941 2023-11-03

Comparison of Letrozole With Lerociclib Versus Letrozole With Placebo Control in Patients With Advanced/Metastatic or Recurrent, Grade 1 or Grade 2 Endometrial Cancer

EQRx International, Inc.

Phase 3 Withdrawn
Gynecologic

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡